Company intelligence / Profile preview

Invictus Medical

San Antonio, Texas, United States

Ownership: Private
Development stage: Commercial

Overview

Invictus Medical has developed and commercialized Neoasis®, an innovative active noise control device designed to reduce harmful sound exposure for preterm infants in neonatal intensive care units. The product is marketed as a means to improve developmental outcomes by providing a quieter, more nurturing environment[1][6].

Therapeutic areas: Neurology
Modalities: Device (specifically, active noise control technology for neonatal care)
Industry: Therapeutic Medical Devices

Partnerships

Not specified; company appears independent with no major disclosed pharma/biotech partnerships.

Beyond the preview

Go deeper on Invictus Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invictus Medical.

Explore the full profile